<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.31549.006</object-id><label>Table 1.</label><caption><title>Baseline characteristics of the participants included in analysis.</title><p><supplementary-material id="table1sdata1"><object-id pub-id-type="doi">10.7554/eLife.31549.007</object-id><label>Table 1&#8212;source data 1.</label><caption><title>Source data for <xref ref-type="table" rid="table1">Table 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-31549-table1-data1-v1.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top"/><th valign="top">LD-SP/SP</th><th valign="top">LD-SP/PIP</th><th valign="top">LD-PIP/PIP</th><th valign="top">LD-PIP/SP</th></tr></thead><tbody><tr><td valign="top">No. subjects</td><td valign="top"/><td valign="top">n&#160;=&#160;4</td><td valign="top">n&#160;=&#160;4</td><td valign="top">n&#160;=&#160;4</td><td valign="top">n&#160;=&#160;4</td></tr><tr><td valign="top">Treatment 1 (T1)</td><td/><td valign="top">Sulfadoxine-pyrimethamine 500 mg/25 mg</td><td valign="top">Sulfadoxine-pyrimethamine 500 mg/25 mg</td><td valign="top">Piperaquine 480 mg</td><td valign="top">Piperaquine 480 mg</td></tr><tr><td valign="top">Treatment 2 (T2)</td><td/><td valign="top">Sulfadoxine-pyrimethamine 1000 mg/50 mg</td><td valign="top">Piperaquine 960 mg</td><td valign="top">Piperaquine 960 mg</td><td valign="top">Sulfadoxine-pyrimethamine 1000 mg/50 mg</td></tr><tr><td valign="top">Sex</td><td/><td/><td/><td/><td/></tr><tr><td valign="top"> Male</td><td valign="bottom">n (%)</td><td valign="top">2 (50%)</td><td valign="top">0 (0%)</td><td valign="top">1 (25%)</td><td valign="top">1 (25%)</td></tr><tr><td valign="top"> Female</td><td valign="bottom">n (%)</td><td valign="top">2 (50%)</td><td valign="top">4 (100%)</td><td valign="top">3 (75%)</td><td valign="top">3 (75%)</td></tr><tr><td valign="top">Age</td><td valign="bottom">Mean (range)</td><td valign="top">24.5 (21&#8211;29)</td><td valign="top">24 (21&#8211;28)</td><td valign="top">21.5 (20&#8211;24)</td><td valign="top">22.5 (20&#8211;27)</td></tr><tr><td valign="top">BMI (<italic>kg/m<sup>2</sup></italic>)</td><td valign="bottom">Mean (range)</td><td valign="top">21 (18&#8211;23)</td><td valign="top">22 (19&#8211;25)</td><td valign="top">24.5 (21&#8211;27)</td><td valign="top">26.5 (24&#8211;29)</td></tr></tbody></table></table-wrap>